Hospitals | April 27, 2026
LVPEI launches Eye and Brain Centre in Hyderabad with support from D. E. Shaw India
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
The capacity addition to be implemented in a phased manner amid evolving business and market dynamics
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Growth was broad-based across segments
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
Subscribe To Our Newsletter & Stay Updated
